International Congress for Lung Cancer, and Head & Neck Cancer
International Congress for Lung Cancer, and Head & Neck Cancer is intended to provide comprehensive updates on biology, diagnosis, screening, and management of lung cancer. Paradigm shift in the treatment options of non-small-cell lung cancer and small-cell lung cancer will be discussed. These webcasts will present data of most promising emerging agents currently in development for the treatment of lung cancer. In-depth discussion of antiangiogenic agents, inhibitors of EGFR pathways and drugs that target multiple signaling pathways will also be given significant focus. Emerging data from ongoing clinical research will be presented.
Available until June 30, 2011
Please note: Nurses and pharmacists can go to www.internationalcancernetwork.com to complete the activity and receive credits.
Jointly Sponsored by International Cancer Network (ICN) and Postgraduate Institute for Medicine
This activity is supported by educational grants from Bristol-Myers Squibb/ImClone Systems, Genentech BioOncology, Lilly USA, LLC.
| Module 1 |
| Credit Hours |
Credit Type |
|
| 0.75 |
AMA PRA |
 |
| Module 2 |
| Credit Hours |
Credit Type |
|
| 1.0 |
AMA PRA |
|
| Module 3 |
| Credit Hours |
Credit Type |
|
| 1.0 |
AMA PRA |
|
| Module 4 |
| Credit Hours |
Credit Type |
|
| 0.75 |
AMA PRA |
|
| Module 5 |
| Credit Hours |
Credit Type |
|
| 1.0 |
AMA PRA |
|
| Module 6 |
| Credit Hours |
Credit Type |
|
| 1.0 |
AMA PRA |
|
| Module 7 |
| Credit Hours |
Credit Type |
|
| 0.75 |
AMA PRA |
|
| Module 8 |
| Credit Hours |
Credit Type |
|
| 0.5 |
AMA PRA |
|
[Back to top]
[Back to Activity Home]
|
